Eculizumab as a Disease‐Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy (<scp>CIDP</scp>): A Case Report
CIDP pathogenesis is characterized by a complex interplay of different immunopathological mechanisms, and the complement system may play a major role. The present case supports the role of complement-dependent toxicity in CIDP and suggests that complement-targeted therapies may represent a well-tolerated and effective alternative for CIDP treatment.
Authors
- Letizia Bertolasi
- Michela Ripolone (ORCID: https://orcid.org/0000-0001-9293-6823)
- Carlo Ferrarese (ORCID: https://orcid.org/0000-0002-7499-6600)
- L. Marzorati
- Maria Letizia Fusco
- M. Frigo
- Edoardo Dalmato Schilke (ORCID: https://orcid.org/0009-0008-6546-5745)
- Claudia Balducci (ORCID: https://orcid.org/0000-0002-3870-835X)
- Diletta Cereda
- Lorenzo Stanzani (ORCID: https://orcid.org/0000-0002-6793-2959)
- Guido Cavaletti (ORCID: https://orcid.org/0000-0003-4128-2406)
- Nico Farina
- Franco Molteni (ORCID: https://orcid.org/0000-0002-0620-6996)
Institutions
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- Azienda Ospedaliera San Gerardo (IT)
- Ospedale Valduce (IT)
- University of Milano-Bicocca (IT)
Publication Details
- Journal
- Journal of the Peripheral Nervous System
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1111/jns.70010
- Citations
- 3
- Primary Topic
- Peripheral Neuropathies and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 4.17